R
Reiko Kunisaki
Researcher at Yokohama City University Medical Center
Publications - 83
Citations - 1552
Reiko Kunisaki is an academic researcher from Yokohama City University Medical Center. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 15, co-authored 51 publications receiving 1085 citations. Previous affiliations of Reiko Kunisaki include Yokohama City University.
Papers
More filters
Journal ArticleDOI
Evidence-based clinical practice guidelines for inflammatory bowel disease
Katsuyoshi Matsuoka,Taku Kobayashi,Fumiaki Ueno,Toshiyuki Matsui,Fumihito Hirai,Nagamu Inoue,Jun Kato,Kenji Kobayashi,Kiyonori Kobayashi,Kazutaka Koganei,Reiko Kunisaki,Satoshi Motoya,Masakazu Nagahori,Hiroshi Nakase,Fumio Omata,Masayuki Saruta,Toshiaki Watanabe,Toshiaki Tanaka,Takanori Kanai,Yoshinori Noguchi,Ken Ichi Takahashi,Kenji Watanabe,Toshifumi Hibi,Yasuo Suzuki,Mamoru Watanabe,Kentaro Sugano,Tooru Shimosegawa +26 more
TL;DR: This English version was produced and edited based on the existing updated guidelines for ulcerative colitis and Crohn’s disease in Japanese, developed with the basic concept of the Grading of Recommendations Assessment, Development, and Evaluation system.
Journal ArticleDOI
Comparison of Targeted vs Random Biopsies for Surveillance of Ulcerative Colitis-Associated Colorectal Cancer.
Toshiaki Watanabe,Yoichi Ajioka,Keiichi Mitsuyama,Kenji Watanabe,Hiroyuki Hanai,Hiroshi Nakase,Reiko Kunisaki,Keiji Matsuda,Ryuichi Iwakiri,Nobuyuki Hida,Shinji Tanaka,Yoshiaki Takeuchi,Kazuo Ohtsuka,Kazunari Murakami,Kiyonori Kobayashi,Yasushi Iwao,Masakazu Nagahori,Bunei Iizuka,Keisuke Hata,Masahiro Igarashi,Ichiro Hirata,Shin-ei Kudo,Takayuki Matsumoto,Fumiaki Ueno,Gen Watanabe,Masahiro Ikegami,Yoko Ito,Koji Oba,Eisuke Inoue,Naoki Tomotsugu,Toru Takebayashi,Kenichi Sugihara,Yasuo Suzuki,Mamoru Watanabe,Toshifumi Hibi +34 more
TL;DR: In a randomized controlled trial, it is found that targeted and random biopsies detect similar proportions of neoplasias and a targeted biopsy appears to be a more cost-effective method.
Journal ArticleDOI
An Open-Label Prospective Randomized Multicenter Study Shows Very Rapid Remission of Ulcerative Colitis by Intensive Granulocyte and Monocyte Adsorptive Apheresis as Compared With Routine Weekly Treatment
Atsushi Sakuraba,Satoshi Motoya,Kenji Watanabe,Masakazu Nishishita,Kazunari Kanke,Toshiyuki Matsui,Yasuo Suzuki,Tadayuki Oshima,Reiko Kunisaki,Takayuki Matsumoto,Hiroyuki Hanai,Ken Fukunaga,Naoki Yoshimura,Toshimi Chiba,Shinsuke Funakoshi,Nobuo Aoyama,Akira Andoh,Hiroshi Nakase,Yohei Mizuta,Ryoichi Suzuki,Taiji Akamatsu,Masahiro Iizuka,Toshifumi Ashida,Toshifumi Hibi +23 more
TL;DR: Intensive GMA in patients with active UC seems to be more efficacious than weekly treatment, and significantly reduced the patients' morbidity time without increasing the incidence of side effects.
Journal ArticleDOI
The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet's disease: indication of anti-TNFα monoclonal antibodies.
Tadakazu Hisamatsu,Fumiaki Ueno,Takayuki Matsumoto,Kiyonori Kobayashi,Kazutaka Koganei,Reiko Kunisaki,Fumihito Hirai,Masakazu Nagahori,Mitsunobu Matsushita,Kenji Kobayashi,Mitsumasa Kishimoto,Mitsuhiro Takeno,Masanori Tanaka,Nagamu Inoue,Toshifumi Hibi,Toshifumi Hibi +15 more
TL;DR: Improved clinical statements regarding indications for anti-TNFα mAbs use were developed and standard therapies in the first edition of consensus statements should be considered as a standard therapy for intestinal BD.
Journal ArticleDOI
A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease
Makoto Naganuma,Makoto Naganuma,Reiko Kunisaki,Naoki Yoshimura,Yoshiaki Takeuchi,Mamoru Watanabe +5 more
TL;DR: Age ≥50 years and the use of immunosuppressants are risk factors for opportunistic infections in patients with IBD.